Compare Cardinal Health Inc (CAH) vs Symbotic Inc (SYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Symbotic Inc — how do they compare? Cardinal Health Inc trades at $228.03 (market cap $53.89B), while Symbotic Inc trades at $43.74 (market cap $5.55B). The key difference: Cardinal Health Inc is far larger — about 9.7× Symbotic Inc's market cap, and Cardinal Health Inc pays a 0.89% dividend while Symbotic Inc pays none. Which is the better fit depends on your goals.
| CAH | SYM | |
|---|---|---|
Market Cap | $53.89B | $5.55B |
Sector | Health | Technology |
52-Week High | $239.71 | $87.30 |
52-Week Low | $146.04 | $38.57 |
Enterprise Value | $58.87B | $3.54B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
Symbotic Inc. (SYM) trades at $42.43, down 2.77% on the day, with technical indicators signaling a bearish trend. The company reported revenue of $2.25 billion in 2025 but posted a net loss of $16.94 million, though gross margins improved to 20.43%. Recent news highlights the acquisition of ARMS Innovations, expanding its AI-powered warehouse optimization solutions. Analyst consensus remains positive with a $57.50 price target, but mixed earnings performance and high valuation ratios present challenges.
Outlook: SYM shows potential in the growing robotics and automation sector, supported by strong operating cash flow and strategic acquisitions. However, profitability concerns, high EV/EBITDA of 240.06, and competitive pressures pose significant risks. Investors should weigh the bullish analyst sentiment against fundamental weaknesses and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Symbotic Inc
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →
